Sakata, Kiyohiko https://orcid.org/0000-0003-2019-1732
Nagata, Yui https://orcid.org/0000-0002-0400-3693
Takeshige, Nobuyuki https://orcid.org/0000-0001-5343-1574
Kikuchi, Jin https://orcid.org/0000-0002-4931-0646
Shikata, Masato https://orcid.org/0000-0002-6857-5404
Ashida, Kenji https://orcid.org/0000-0001-8753-6016
Nomura, Masatoshi https://orcid.org/0000-0002-0725-3161
Morioka, Motohiro https://orcid.org/0000-0001-7179-1258
Article History
Received: 14 September 2020
Accepted: 7 March 2021
First Online: 18 March 2021
Declarations
:
: This study was approved by the ethics committee of the Kurume University School of Medicine (approval number: 18019).
: All patients concurred with the proposed treatment plan after all options for the management of acromegaly were clearly explained. Informed consent was obtained from all individual participants included in this study.
: All authors have read and approved the final manuscript.
: The authors declare no competing interests.